Hazardous Waste Pharmaceuticals Sewer Prohibition Kristie Shipley - - PowerPoint PPT Presentation

hazardous waste pharmaceuticals sewer prohibition
SMART_READER_LITE
LIVE PREVIEW

Hazardous Waste Pharmaceuticals Sewer Prohibition Kristie Shipley - - PowerPoint PPT Presentation

Hazardous Waste Pharmaceuticals Sewer Prohibition Kristie Shipley Hazardous Waste Program Division of Environmental Response & Revitalization Agenda Introduction Background Applicability/Definitions Management Questions


slide-1
SLIDE 1

Hazardous Waste Pharmaceuticals Sewer Prohibition

Kristie Shipley Hazardous Waste Program Division of Environmental Response & Revitalization

slide-2
SLIDE 2

Agenda

▪ Introduction ▪ Background ▪ Applicability/Definitions ▪ Management ▪ Questions

slide-3
SLIDE 3

US EPA Final Rule

Final Rule: Management Standards for Hazardous Waste Pharmaceuticals

▪ § 266.505 Sewer Prohibition- August 21, 2019

slide-4
SLIDE 4

Background

RCRA domestic sewage exclusion in § 261.4(a)(1)(ii)

▪ Any mixture of domestic sewage and other wastes that passes through a sewer system to a publicly-

  • wned treatment works for treatment.

▪ Not considered solid wastes up to this point

slide-5
SLIDE 5

Clean Water Act

Ignitable and some reactive and corrosive wastes are already prohibited from being discharged to the sewer system under the Clean Water Act § 403.5(b)

slide-6
SLIDE 6

Authority

Hazardous and Solid Waste Amendments (HSWA) 1984

▪ Allows for revision of regulations to ensure substances which pass through a sewer system to POTW are adequately controlled

slide-7
SLIDE 7

Background

▪ No pollutant discharge limits that apply to healthcare facilities discharging pharmaceuticals to POTWs ▪ Wastewater treatment is not designed to remove pharmaceuticals

slide-8
SLIDE 8

Background

Projected to prevent the flushing of 1,644 to 2,300 tons of hazardous waste pharmaceuticals annually

slide-9
SLIDE 9

Applicability

▪ All healthcare facilities that generate, accumulate, or otherwise handle hazardous waste pharmaceuticals

▪ Including CESQGs

▪ Reverse distributors engaged in the management of prescription hazardous waste pharmaceuticals

slide-10
SLIDE 10

Definition

Healthcare facility: (1) provide preventative, diagnostic, therapeutic, rehabilitative, maintenance or palliative care, and counseling, service, assessment or procedure with respect to the physical or mental condition, or functional status, of a human or animal or that affects the structure or function of the human or animal body

  • any drug or dietary supplement for use by humans or
  • ther animals; any electronic nicotine delivery system, or any liquid nicotine packaged for

retail for use in electronic nicotine delivery systems (e.g., pre-filled cartridges or vials).

slide-11
SLIDE 11

Definition

Healthcare facility: (2) distribute, sell, or dispense pharmaceuticals, including OTC pharmaceuticals, dietary supplements, homeopathic drugs, or prescription pharmaceuticals

  • any drug or dietary supplement for use by humans or
  • ther animals; any electronic nicotine delivery system, or any liquid nicotine packaged for

retail for use in electronic nicotine delivery systems (e.g., pre-filled cartridges or vials).

slide-12
SLIDE 12

Healthcare Facilities

Hospitals Psychiatric hospitals Ambulatory surgical centers Health clinics Physicians’

  • ffices

Optical & dental providers Chiropractors Long term care facilities Ambulance services Pharmacies Retailers of OTC medications Veterinary clinics/hospitals

slide-13
SLIDE 13

Definition

Reverse distributor: Any person that receives and accumulates prescription pharmaceuticals that are potentially creditable hazardous waste pharmaceuticals for the purpose of facilitating or verifying manufacturer credit

  • any drug or dietary supplement for use by humans or
  • ther animals; any electronic nicotine delivery system, or any liquid nicotine packaged for

retail for use in electronic nicotine delivery systems (e.g., pre-filled cartridges or vials).

slide-14
SLIDE 14

Definition

Pharmaceutical:

Any drug or dietary supplement for use by humans or other animals, any electronic nicotine delivery system, or any liquid nicotine packaged for retail for use in electronic nicotine delivery systems (e.g., pre-filled cartridges or vials).

  • any drug or dietary supplement for use by humans
  • r other animals; any electronic nicotine delivery system, or any liquid nicotine

packaged for retail for use in electronic nicotine delivery systems (e.g., pre-filled cartridges or vials).

slide-15
SLIDE 15

Pharmaceuticals

Dietary supplements Prescription drugs OTC drugs Homeopathic drugs Compounded drugs Investigational drugs Pharmaceuticals remaining in containers Personal protective equipment (contaminated) Clean-up material (pharmaceutical spills)

slide-16
SLIDE 16

Hazardous Waste Pharmaceutical

▪ Listed hazardous waste

– Approximately 30 products listed on the P and U lists with pharmaceutical uses

▪ Characteristic hazardous waste

– Ignitable, corrosive, reactive or toxic

slide-17
SLIDE 17

DEA Controlled Substances

Name of Drug Other Name(s) Medical Uses RCRA HW Code DEA CS Schedule Chloral/ Chloral hydrate

Acetaldehyde, trichloro; Aquachloral Noctec, Somnote, Supprettes

Sedative U034 T

  • xic

IV Fentanyl sublingual spray Subsys Analgesic D001 ignitable II Phenobarbital Bellergal-S Donnatal Luminal Anticonvulsant D001 ignitable IV T estosterone gels/solutions Androgel Axiron Fortesta,T estim Hormone D001 ignitable III Valium injectable/gel Diazepam Diastat Anti-anxiety D001 ignitable IV

slide-18
SLIDE 18

Applicability Summary

Are you a healthcare facility

  • f reverse distributor?

Do you generate pharmaceutical waste? Is it a hazardous waste?

slide-19
SLIDE 19

Management

Need to manage as hazardous waste

▪ Chapter 3745-52 Generator Standards

Generator categories:

▪ CESQG: ≤ 1 kg acute, ≤ 100 kg hazardous ▪ SQG: > 100 kg and < 1,000 kg hazardous ▪ LQG: > 1 kg acute, ≥ 1,000 kg hazardous

slide-20
SLIDE 20

Management

Satellite accumulation (SQG/LQG)

▪ 55 gallons of non-acute ▪ 1 quart of acute ▪ At or near the point of generation

slide-21
SLIDE 21

Management

Container management (SQG/LQG)

▪ Good condition ▪ Compatible with waste ▪ Labeled as hazardous waste ▪ Maintain aisle space and lids ▪ Conduct weekly inspections ▪ Label accumulation start date (unless a satellite accumulation area)

slide-22
SLIDE 22

Management

Training (SQG/LQG)

▪ All employees must be thoroughly familiar with proper waste handling and emergency procedures, relevant to their responsibilities

Emergency equipment (SQG/LQG)

▪ Internal communication or alarm system ▪ Telephone or two-way radio ▪ Fire, spill control and decontamination equipment

slide-23
SLIDE 23

Management

▪ 180-day storage limit SQG ▪ 90-day storage limit LQG

slide-24
SLIDE 24

Management

Emergency procedures:

▪ (SQG) Emergency Coordinator’s response required ▪ (LQG) Written contingency plan and emergency procedures required

slide-25
SLIDE 25

Management

Land Disposal Restriction (SQG/LQG)

▪ Determine if waste must be treated before it can be land disposed (or write on manifest that a determination has not been made) ▪ One-time written notice to each treatment storage disposal facility receiving your hazardous waste

slide-26
SLIDE 26

Management

Reporting ▪ (LQG) Biennial report due March 1st in even numbered years for previous year

slide-27
SLIDE 27

Management

Recordkeeping (SQG/LQG)

▪ Manifests ▪ LDR notification ▪ Exception reports ▪ Waste evaluation ▪ Training ▪ Biennial Report ▪ (kept on-site for at least 3 years)

slide-28
SLIDE 28

Management

Hazardous waste pharmaceuticals should NOT be placed in red sharps containers

▪ Biohazardous waste/infectious waste

slide-29
SLIDE 29

Summary

August 21st-Hazardous waste pharmaceuticals may not be sewered (drain / flushing) Sewering of any pharmaceuticals is highly discouraged

slide-30
SLIDE 30

Questions?

Kristie Shipley 614-728-5363 Kristie.Shipley@epa.ohio.gov Compliance Assistance Hotline: (800) 329-7518 (anonymous)